BIOMARIN PHARMACEUTICAL INC - FORM 10-K/A - EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS, LLP - March 25, 2010

Attached files

file filename
10-K/A - FORM 10-K/A - BIOMARIN PHARMACEUTICAL INCd10ka.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) - BIOMARIN PHARMACEUTICAL INCdex312.htm
EX-99.1 - BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS - BIOMARIN PHARMACEUTICAL INCdex991.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - BIOMARIN PHARMACEUTICAL INCdex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) - BIOMARIN PHARMACEUTICAL INCdex311.htm

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-136963, 333-85368, 333-84787) of BioMarin Pharmaceutical Inc. of our report dated March 25, 2010 relating to the financial statements of BioMarin/Genzyme LLC, which appears in this Form 10-K/A.

 

/s/ PricewaterhouseCoopers LLP

 

Boston, Massachusetts

March 25, 2010

Stock widget

Investing forum

BIOMARIN PHARMACEUTICAL INC Reports